IR-Med Inc. (IRME)
OTCMKTS · Delayed Price · Currency is USD
0.0151
+0.0031 (26.21%)
At close: Aug 26, 2025
IR-Med Market Cap
IR-Med has a market cap or net worth of $1.17 million as of September 5, 2025. Its market cap has decreased by -98.00% in one year.
Market Cap
1.17M
Enterprise Value
1.36M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since May 18, 2009, IR-Med's market cap has decreased from 6.41M to 1.17M, a decrease of -81.75%. That is a compound annual growth rate of -9.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2025 | 1.17M | -96.48% |
| Dec 31, 2024 | 33.20M | -58.72% |
| Dec 22, 2023 | 80.42M | 133.75% |
| Dec 30, 2022 | 34.40M | -75.79% |
| Dec 29, 2021 | 142.12M | 76,823.79% |
| Dec 31, 2020 | 184.76K | -96.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 891.61M |
| Elite Pharmaceuticals | 757.64M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 631.79M |
| CytoDyn | 401.20M |
| Northwest Biotherapeutics | 394.86M |
| American Oncology Network | 353.52M |